loader image
Sunday, December 21, 2025
87.1 F
McAllen
- Advertisement -

The Importance of Prostate Cancer Exams

Translate to Spanish or other 102 languages!

September is Prostate Cancer Awareness Month, which is a good time to remind men about the importance of prostate cancer screenings. Image for illustration purposes
September is Prostate Cancer Awareness Month, which is a good time to remind men about the importance of prostate cancer screenings. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – September is Prostate Cancer Awareness Month, which is a good time to remind men about the importance of prostate cancer screenings.

If you’ve never had one before, you may wonder what to expect.

“If the patient agrees to a prostate cancer screening, that can be done very easily through a blood test called PSA, Prostate Specific Antigen, which is an enzyme that is specific to the prostate and that is known to rise in cases of cancer. Like everything in medicine, things are not very simple, and PSA can be elevated for a myriad of reasons besides prostate cancer,” said Gabriel Gavrilescu, MD, internal medicine physician at Cleveland Clinic.

- Advertisement -

Dr. Gavrilescu said some other reasons a man’s PSA levels are elevated could be due to inflammation of the prostate, or infection of the prostate.

Certain physical activities, like riding a bike, could also play a role.

Typically, when PSA levels are high, Dr. Gavrilescu said they will conduct additional testing, which could include a digital rectal exam, more lab work or imaging.

Based on those results, a biopsy may be performed.

- Advertisement -

Dr. Gavrilescu notes that the size of a man’s prostate doesn’t always mean something is wrong either.

“I think that one of the common misconceptions is that the size of the prostate does not correlate necessarily with benign or malignancy. We can have a very large prostate and no cancer, and we can have a small prostate and cancer. So, the size does not always matter in terms of assessing something being benign or malignant. It is usually the tissue diagnosis and other clinical elements that suggest one way or another,” he said.

According to the CDC, prostate cancer screenings are recommended for men between the ages of 55 to 69.

However, some men may need to start screenings earlier depending on family history and other risk factors.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×